Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy.

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2015 Feb 11;16(2):3856-69. doi: 10.3390/ijms16023856.

PMID:
25679447
[PubMed - in process]
Free Article
2.

Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy.

Eminaga O, Bögemann M, Breil B, Titze U, Wötzel F, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Nov;32(8):1317-26. doi: 10.1016/j.urolonc.2014.04.018. Epub 2014 Jun 2.

PMID:
24893699
[PubMed - in process]
3.

Prostate Cancers detected on Repeat Prostate Biopsies show Spatial Distributions that differ from those detected on the Initial Biopsies.

Eminaga O, Hinkelammert R, Abba M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M, Semjonow A.

BJU Int. 2014 Feb 19. doi: 10.1111/bju.12691. [Epub ahead of print]

PMID:
24552505
[PubMed - as supplied by publisher]
4.

Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.

Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L, Semjonow A.

Urol Oncol. 2014 May;32(4):403-12. doi: 10.1016/j.urolonc.2013.10.001. Epub 2013 Dec 12.

PMID:
24332639
[PubMed - in process]
5.

[A Mycotic Pulmonary Artery Aneurysm in an Intravenous Drug User.]

Huwer H, Gamrekeli A, Schäfer H, Eltze E.

Zentralbl Chir. 2013 Oct 16. [Epub ahead of print] German. No abstract available.

PMID:
24132673
[PubMed - as supplied by publisher]
6.

Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2013 Jun 3;14(6):11816-29. doi: 10.3390/ijms140611816.

PMID:
23736690
[PubMed - in process]
Free PMC Article
7.

High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: existence of HGPIN near prostate cancer.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Semjonow A.

Prostate. 2013 Jul;73(10):1115-22. doi: 10.1002/pros.22660. Epub 2013 Mar 26.

PMID:
23532797
[PubMed - indexed for MEDLINE]
8.

The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.

Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Jan;32(1):32.e17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19.

PMID:
23434425
[PubMed - indexed for MEDLINE]
9.

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.

Eminaga O, Abbas M, Hinkelammert R, Titze U, Bettendorf O, Eltze E, Ozgür E, Semjonow A.

BMC Med Inform Decis Mak. 2012 Dec 3;12:141. doi: 10.1186/1472-6947-12-141.

PMID:
23206574
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Pulmonary paraganglioma: case report and literature review].

Huwer H, Kalweit G, Schäfer H, Eltze E.

Pneumologie. 2011 Dec;65(12):742-4. doi: 10.1055/s-0031-1286635. Epub 2011 Nov 2. Review. German.

PMID:
22048873
[PubMed - indexed for MEDLINE]
Free Article
11.

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.

Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, Larsson A, Landegren UD, Kamali-Moghaddam M.

Proc Natl Acad Sci U S A. 2011 May 24;108(21):8809-14. doi: 10.1073/pnas.1019330108. Epub 2011 May 9.

PMID:
21555566
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.

Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B.

Int J Cancer. 2012 Feb 1;130(3):611-21. doi: 10.1002/ijc.26064. Epub 2011 May 9.

PMID:
21400514
[PubMed - indexed for MEDLINE]
13.

Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.

Gaisa NT, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A, Knuechel R.

Virchows Arch. 2011 Mar;458(3):301-12. doi: 10.1007/s00428-010-1017-2. Epub 2010 Dec 7.

PMID:
21136076
[PubMed - indexed for MEDLINE]
14.

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens.

Eminaga O, Hinkelammert R, Semjonow A, Neumann J, Abbas M, Koepke T, Bettendorf O, Eltze E, Dugas M.

BMC Med Inform Decis Mak. 2010 Nov 15;10:71. doi: 10.1186/1472-6947-10-71.

PMID:
21078179
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss?

Köpke T, Oberpenning F, Bettendorf O, Eltze E, Herrmann E, Hertle L, Weining C, Wulfing C, Semjonow A.

Anticancer Res. 2010 May;30(5):1823-7.

PMID:
20592386
[PubMed - indexed for MEDLINE]
16.

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.

Bednarz N, Eltze E, Semjonow A, Rink M, Andreas A, Mulder L, Hannemann J, Fisch M, Pantel K, Weier HU, Bielawski KP, Brandt B.

Clin Cancer Res. 2010 Jul 1;16(13):3340-8. doi: 10.1158/1078-0432.CCR-10-0150. Epub 2010 Jun 30.

PMID:
20592016
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum.

Semjonow A, Köpke T, Eltze E, Pepping-Schefers B, Bürgel H, Darte C.

Clin Biochem. 2010 Jul;43(10-11):926-8. doi: 10.1016/j.clinbiochem.2010.04.062. Epub 2010 May 8.

PMID:
20450900
[PubMed - indexed for MEDLINE]
18.

Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model.

Herrmann E, Tiemann A, Eltze E, Bolenz C, Bremer C, Persigehl T, Hertle L, Wülfing C.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1455-62. doi: 10.1007/s00432-009-0593-5. Epub 2009 May 9.

PMID:
19430814
[PubMed - indexed for MEDLINE]
19.

Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.

Eltze E, Wild PJ, Wülfing C, Zwarthoff EC, Burger M, Stoehr R, Korsching E, Hartmann A.

Eur Urol. 2009 Nov;56(5):837-45. doi: 10.1016/j.eururo.2008.10.003. Epub 2008 Oct 11.

PMID:
18945538
[PubMed - indexed for MEDLINE]
20.

Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.

Bierer S, Herrmann E, Köpke T, Neumann J, Eltze E, Hertle L, Wülfing C.

Oncol Rep. 2008 Oct;20(4):721-5.

PMID:
18813809
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk